153 related articles for article (PubMed ID: 9885379)
1. Mutations and amplification of oncogenes in endometrial cancer.
Niederacher D; An HX; Cho YJ; Hantschmann P; Bender HG; Beckmann MW
Oncology; 1999; 56(1):59-65. PubMed ID: 9885379
[TBL] [Abstract][Full Text] [Related]
2. Multiple genetic lesions in laryngeal squamous cell carcinomas.
Fracchiolla NS; Pignataro L; Capaccio P; Trecca D; Boletini A; Ottaviani A; Polli E; Maiolo AT; Neri A
Cancer; 1995 Mar; 75(6):1292-301. PubMed ID: 7882279
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic potential of c-erbB-2 and its association with c-K-ras in premalignant and malignant lesions of the human uterine endometrium.
Manavi M; Bauer M; Baghestanian M; Berger A; Kucera E; Pischinger K; Battistutti W; Czerwenka K
Tumour Biol; 2001; 22(5):299-309. PubMed ID: 11553860
[TBL] [Abstract][Full Text] [Related]
4. The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancer.
Esteller M; García A; Martínez-Palones JM; Xercavins J; Reventós J
Eur J Cancer; 1997 Sep; 33(10):1572-7. PubMed ID: 9389917
[TBL] [Abstract][Full Text] [Related]
5. K-RAS point mutation, and amplification of C-MYC and C-ERBB2 in colon adenocarcinoma.
Kruszewski W; Kowara R; Rzepko R; Warezak C; Zieliński J; Gryglewski G; Kopacz A; Jastrzebski T; Pawełczyk T
Folia Histochem Cytobiol; 2004; 42(3):173-9. PubMed ID: 15493579
[TBL] [Abstract][Full Text] [Related]
6. Cancer genes alterations and HPV infection in oral squamous cell carcinoma.
Popović B; Jekić B; Novaković I; Luković L; Konstantinović V; Babić M; Milasin J
Int J Oral Maxillofac Surg; 2010 Sep; 39(9):909-15. PubMed ID: 20579853
[TBL] [Abstract][Full Text] [Related]
7. c-myc and c-Ha-ras cellular oncogenes and human papillomaviruses in benign and malignant cutaneous lesions.
Pelisson I; Soler C; Pechoux C; Chignol MC; Viac J; Euvrard S; Chardonnet Y
J Dermatol Sci; 1992 Jan; 3(1):56-67. PubMed ID: 1317208
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
9. Quantitative detection of amplification of proto-oncogenes in breast cancer.
Chen Y; Dong J; Lu Y; McGee JO
Chin Med J (Engl); 1995 Nov; 108(11):849-54. PubMed ID: 8585979
[TBL] [Abstract][Full Text] [Related]
10. Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma.
Barrios C; Castresana JS; Ruiz J; Kreicbergs A
J Orthop Res; 1993 Jul; 11(4):556-63. PubMed ID: 8101872
[TBL] [Abstract][Full Text] [Related]
11. PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.
Konopka B; Janiec-Jankowska A; Kwiatkowska E; Najmoła U; Bidziński M; Olszewski W; Goluda C
Hum Pathol; 2011 Nov; 42(11):1710-9. PubMed ID: 21531001
[TBL] [Abstract][Full Text] [Related]
12. Expression of cellular oncogenes in human gastric carcinoma: c-myc, c-erb B2, and c-Ha-ras.
Kim YJ; Ghu HD; Kim DY; Kim HJ; Kim SK; Park CS
J Surg Oncol; 1993 Nov; 54(3):167-70. PubMed ID: 8412172
[TBL] [Abstract][Full Text] [Related]
13. Oncogene profile of papillary thyroid carcinoma.
Sugg SL; Ezzat S; Zheng L; Freeman JL; Rosen IB; Asa SL
Surgery; 1999 Jan; 125(1):46-52. PubMed ID: 9889797
[TBL] [Abstract][Full Text] [Related]
14. Oncogenesis in ovarian cancer.
Børresen AL
Acta Obstet Gynecol Scand Suppl; 1992; 155():25-30. PubMed ID: 1502889
[TBL] [Abstract][Full Text] [Related]
15. Novel combination of c-myc, N-myc and N-ras oncogene alteration in brain tumors.
Sauceda R; Ocadiz R; Gutierrez AL; Salcedo M; Ortega V; Figueroa HH; Gariglio P
Brain Res; 1988 Apr; 427(2):123-32. PubMed ID: 2838125
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations of cancer-related genes in glass fiber-induced transformed cells.
Whong WZ; Gao HG; Zhou G; Ong T
J Toxicol Environ Health A; 1999 Mar; 56(6):397-404. PubMed ID: 10096362
[TBL] [Abstract][Full Text] [Related]
18. KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer.
Birkeland E; Wik E; Mjøs S; Hoivik EA; Trovik J; Werner HM; Kusonmano K; Petersen K; Raeder MB; Holst F; Øyan AM; Kalland KH; Akslen LA; Simon R; Krakstad C; Salvesen HB
Br J Cancer; 2012 Dec; 107(12):1997-2004. PubMed ID: 23099803
[TBL] [Abstract][Full Text] [Related]
19. Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysis.
Alexander-Sefre F; Salvesen HB; Ryan A; Singh N; Akslen LA; MacDonald N; Wilbanks G; Jacobs IJ
Gynecol Oncol; 2003 Oct; 91(1):218-25. PubMed ID: 14529685
[TBL] [Abstract][Full Text] [Related]
20. [Carcinogenic mechanisms of multiple genes in cervical carcinoma].
Huang G; Xiao X; Huang Y; Huang R
Hua Xi Yi Ke Da Xue Xue Bao; 1996 Mar; 27(1):5-9. PubMed ID: 9208611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
